7241 |
7MXE |
MO_C |
8ANC195 Fab |
HIV-1 BG505 SOSIP gp41 |
Homo sapiens, Human immunodeficiency virus 1, Macaca mulatta |
EM |
3.7 | 10.1038/s41541-021-00387-4 |
7242 |
7MXE |
MO_P |
8ANC195 Fab |
HIV-1 BG505 SOSIP gp120 |
Homo sapiens, Human immunodeficiency virus 1, Macaca mulatta |
EM |
3.7 | 10.1038/s41541-021-00387-4 |
7243 |
7MXE |
AB_J |
8ANC195 Fab |
HIV-1 BG505 SOSIP gp120 |
Homo sapiens, Human immunodeficiency virus 1, Macaca mulatta |
EM |
3.7 | 10.1038/s41541-021-00387-4 |
7244 |
7MXE |
AB_F |
8ANC195 Fab |
HIV-1 BG505 SOSIP gp41 |
Homo sapiens, Human immunodeficiency virus 1, Macaca mulatta |
EM |
3.7 | 10.1038/s41541-021-00387-4 |
7245 |
7MXE |
RW_J |
Ab1245 Fab |
HIV-1 BG505 SOSIP gp120 |
Homo sapiens, Human immunodeficiency virus 1, Macaca mulatta |
EM |
3.7 | 10.1038/s41541-021-00387-4 |
7246 |
7N0A |
BA_C |
MSC1 Fab |
Leukemia inhibitory factor (LIF) |
Homo sapiens |
XRD |
3.1 | 10.1158/1078-0432.CCR-21-1888 |
7247 |
7N64 |
HL_A |
G32R7 Fab |
SARS-CoV-2 spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
4.2 | 10.1101/2021.03.10.434840 |
7248 |
7N64 |
HL_B |
G32R7 Fab |
SARS-CoV-2 spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Homo sapiens |
EM |
4.2 | 10.1101/2021.03.10.434840 |
7249 |
7N65 |
CD_A |
QA013.2 Fab |
HIV-1 BG505 SOSIP gp120 |
Human immunodeficiency virus 1, Homo sapiens |
EM |
4.15 | 10.7554/eLife.68110 |
7250 |
7N65 |
GH_E |
QA013.2 Fab |
HIV-1 BG505 SOSIP gp120 |
Human immunodeficiency virus 1, Homo sapiens |
EM |
4.15 | 10.7554/eLife.68110 |
7251 |
7N65 |
KL_I |
QA013.2 Fab |
HIV-1 BG505 SOSIP gp120 |
Human immunodeficiency virus 1, Homo sapiens |
EM |
4.15 | 10.7554/eLife.68110 |
7252 |
7N8Q |
HL_G |
RhDH677.3 Fab |
HIV-1 clade A/E 93TH057 gp120 |
Human immunodeficiency virus 1, synthetic construct, Macaca mulatta |
XRD |
2.9 | 10.3389/fimmu.2021.787603 |
7253 |
7N8Q |
CD_A |
DH677.3 Fab |
HIV-1 clade A/E 93TH057 gp120 |
Human immunodeficiency virus 1, synthetic construct, Macaca mulatta |
XRD |
2.9 | 10.3389/fimmu.2021.787603 |
7254 |
7N9T |
D_C |
17 Nanobody |
SARS-CoV-2 spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Lama glama |
EM |
3.18 | 10.1038/s41467-021-24963-3 |
7255 |
7N9T |
F_B |
17 Nanobody |
SARS-CoV-2 spike glycoprotein |
Severe acute respiratory syndrome coronavirus 2, Lama glama |
EM |
3.18 | 10.1038/s41467-021-24963-3 |
7256 |
7N9V |
B_C |
GYAR Nanobody |
HIV-1 capsid protein |
Human immunodeficiency virus 1, Lama glama |
XRD |
3.45 | Not available or To be published |
7257 |
7N9V |
F_G |
GYAR Nanobody |
HIV-1 capsid protein |
Human immunodeficiency virus 1, Lama glama |
XRD |
3.45 | Not available or To be published |
7258 |
7N9V |
H_K |
GYAR Nanobody |
HIV-1 capsid protein |
Human immunodeficiency virus 1, Lama glama |
XRD |
3.45 | Not available or To be published |
7259 |
7N9V |
L_A |
GYAR Nanobody |
HIV-1 capsid protein |
Human immunodeficiency virus 1, Lama glama |
XRD |
3.45 | Not available or To be published |
7260 |
7N9V |
E_D |
GYAR Nanobody |
HIV-1 capsid protein |
Human immunodeficiency virus 1, Lama glama |
XRD |
3.45 | Not available or To be published |